SCHEMBL23157264

SCHEMBL23157264

COc1ccc(C(OC[C@H]2O[C@@H](n3cnc4c(=O)[nH]c(NC(=O)C(C)C)nc43)C[C@@H]2P(=O)(O)Oc2ccccc2Cl)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.48
▸ TYMP P19971 8/20 0.43
▸ TAS1R3 Q7RTX0 1/20 0.39
▸ TAS1R1 Q7RTX1 1/20 0.39
▸ POLA1 P09884 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ NT5E P21589 1/20 0.33
▸ IMPDH2 P12268 2/20 0.33
▸ IMPDH1 P20839 1/20 0.33
▸ PDE5A O76074 3/20 0.32
▸ PDE1B Q01064 3/20 0.32
▸ PDE4D Q08499 3/20 0.32
▸ PDE9A O76083 2/20 0.32
▸ PDE4A P27815 2/20 0.32
▸ PDE4B Q07343 2/20 0.32
▸ PDE4C Q08493 2/20 0.32
▸ PDE7A Q13946 1/20 0.32
▸ PDE10A Q9Y233 1/20 0.32
▸ PDE8A O60658 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15083528 0.91 KDM4E (0.49) KDM4ETYMPTAS1R3TAS1R1POLA1
SCHEMBL21828784 0.85 TYMP (0.59) KDM4ETYMPTAS1R3TAS1R1POLA1
SCHEMBL3821714 0.85 TYMP (0.59) KDM4ETYMPTAS1R3TAS1R1POLA1
SCHEMBL12714672 0.85 TYMP (0.59) KDM4ETYMPTAS1R3TAS1R1POLA1
SCHEMBL2281663 0.85 TYMP (0.59) KDM4ETYMPTAS1R3TAS1R1POLA1
SCHEMBL31556051 0.85 TYMP (0.59) KDM4ETYMPTAS1R3TAS1R1POLA1
SCHEMBL10788490 0.85 KDM4E (0.49) KDM4ETYMPTAS1R3TAS1R1POLA1
SCHEMBL29799112 0.84 KDM4E (0.52) KDM4ETYMPTAS1R3TAS1R1POLA1
SCHEMBL3820892 0.84 KDM4E (0.56) KDM4ETYMPTAS1R3TAS1R1POLA1
SCHEMBL26190487 0.83 KDM4E (0.53) KDM4ETYMPTAS1R3TAS1R1POLA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2813512-B1 PEPTIDE-COMPOUND CYCLIZATION METHOD CHUGAI PHARMACEUTICAL CO LTD (JP) 2021-03-31 — — EP disclosed
Send feedback